CIBC Private Wealth Group’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$623 Hold
75
﹤0.01% 3002
2025
Q3
$1.09K Hold
75
﹤0.01% 2808
2025
Q2
$844 Hold
75
﹤0.01% 2780
2025
Q1
$432 Hold
75
﹤0.01% 2905
2024
Q4
$833 Hold
75
﹤0.01% 2812
2024
Q3
$611 Hold
75
﹤0.01% 2957
2024
Q2
$1.02K Sell
75
-88
-54% -$2.63K ﹤0.01% 2898
2024
Q1
$7.3K Buy
+163
New +$8.44K ﹤0.01% 2393

Other funds holding DNA

CIBC Private Wealth Group's DNA Position: Q4 2025 in Review

CIBC Private Wealth Group held its Ginkgo Bioworks (DNA) position steady in Q4 2025 at 75 shares worth $623. The position accounts for ﹤0.01% of the portfolio, ranked #3002.

CIBC Private Wealth Group first reported a position in DNA in Q1 2024 and has held it in 8 quarters since. The position peaked at $7.3K in Q1 2024. 180 funds tracked by Wall St. Rank hold DNA as of Q4 2025.

  • CIBC Private Wealth Group held 75 shares of Ginkgo Bioworks worth $623 as of Q4 2025.
  • CIBC Private Wealth Group left its Ginkgo Bioworks share count unchanged in Q4 2025.
  • Ginkgo Bioworks made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #3002 holding.
  • CIBC Private Wealth Group first reported a position in Ginkgo Bioworks in Q1 2024 and has held it in 8 quarters since.
  • CIBC Private Wealth Group's Ginkgo Bioworks position peaked at $7.3K in Q1 2024.
  • 180 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.